Literature DB >> 9631776

Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995.

Z Liu1, K L Shilkret, L Finelli.   

Abstract

STUDY
OBJECTIVE: To evaluate physician prescribing practices for the initial therapy for tuberculosis (TB) according to the recommendations of the Centers for Disease Control and Prevention (CDC) and American Thoracic Society (ATS).
DESIGN: Cross-sectional study.
SETTING: Statewide TB surveillance system in New Jersey, 1994 to 1995. PATIENTS: We studied 1,230 culture-positive TB patients who were alive at diagnosis and whose isolates were tested for isoniazid susceptibility.
RESULTS: Almost all TB patients (98%) were reported from counties with an isoniazid-resistant proportion of 4% or more, which is the minimum level for implementation of an initial four-drug regimen recommended by CDC/ATS. Overall, 36% of the 1,230 patients were not initially treated with four or more drugs. Multivariate analyses found that non-Hispanic white patients were more likely to be treated with fewer than four drugs than were non-Hispanic black patients. Private practitioners and physicians at chest clinics were about five times more likely to prescribe fewer than four drugs initially than were physicians at the hospital where a national TB center is located.
CONCLUSION: A substantial proportion of physicians did not initially treat their TB patients according to the CDC/ATS recommendations. The results suggest that New Jersey physicians should be better informed about the recommendation and the high level of drug resistance in the communities they serve to assure that TB patients receive appropriate initial therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631776     DOI: 10.1378/chest.113.6.1446

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message.

Authors:  P McGettigan; J Golden; J Fryer; R Chan; J Feely
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

2.  HIV testing of tuberculosis patients by public and private providers in New York City.

Authors:  Pamela W Klein; Tiffany G Harris; Peter A Leone; Audrey E Pettifor
Journal:  J Community Health       Date:  2014-06

3.  Physician characteristics and the reported effect of evidence-based practice guidelines.

Authors:  Christine E Sammer; Kristine Lykens; Karan P Singh
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

Review 4.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

5.  The impact of physician training and experience on the survival of patients with active tuberculosis.

Authors:  Kamran Khan; Ann Campbell; Tamara Wallington; Michael Gardam
Journal:  CMAJ       Date:  2006-09-26       Impact factor: 8.262

6.  Initial drug regimen for active tuberculosis cases in Montreal, 1995 to 1998.

Authors:  P Rivest; T N Tannenbaum
Journal:  Can J Infect Dis       Date:  2001-03

7.  Rethinking the socioeconomics and geography of tuberculosis among foreign-born residents of New Jersey, 1994-1999.

Authors:  Amy L Davidow; Bonita T Mangura; Eileen C Napolitano; Lee B Reichman
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

8.  Tuberculosis treatment managed by providers outside the Public Health Department: lessons for the Affordable Care Act.

Authors:  Melissa Ehman; Jennifer Flood; Pennan M Barry
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

9.  Treatment of Active Tuberculosis in Chicago, 2008-2011: The Role of Public Health Departments.

Authors:  Reid Fletcher; Joshua D Jones; Neha S Shah
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.